Who is a ‘healthy subject’?—consensus results on pivotal eligibility criteria for clinical trials

INTRODUCTION/METHODS: A discussion forum was hosted by the German not-for-profit Association for Applied Human Pharmacology (AGAH e.V.) to critically review key eligibility criteria and stopping rules for clinical trials with healthy subjects, enrolling stakeholders from the pharmaceutical industry,...

Descripción completa

Detalles Bibliográficos
Autores principales: Breithaupt-Groegler, Kerstin, Coch, Christoph, Coenen, Martin, Donath, Frank, Erb-Zohar, Katharina, Francke, Klaus, Goehler, Karin, Iovino, Mario, Kammerer, Klaus Peter, Mikus, Gerd, Rengelshausen, Jens, Sourgens, Hildegard, Schinzel, Reinhard, Sudhop, Thomas, Wensing, Georg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5350217/
https://www.ncbi.nlm.nih.gov/pubmed/28064353
http://dx.doi.org/10.1007/s00228-016-2189-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5350217/
https://www.ncbi.nlm.nih.gov/pubmed/28064353
http://dx.doi.org/10.1007/s00228-016-2189-8

Ejemplares similares